GlassScriptPhysician profile
Rosalyn M Aranas
NPI 1568629822
$9,444.39
in general payments reported to CMS, 2019-2025
50 companies · $634 in 2025
The $634 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,391 · 2020: $940 · 2021: $1,805 · 2022: $1,981 · 2023: $1,900 · 2024: $794 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,082 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,081.57 |
| Education | $246.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,655.04 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Harmony Biosciences LLC | $1,416.68 | 2020-2025 | Wakix |
| Ucb, INC. | $769.07 | 2019-2024 | Briviact, Rystiggo |
| Abbvie INC. | $723.07 | 2021-2025 | Qulipta, Ubrelvy |
| Amgen INC. | $394.22 | 2019-2023 | Aimovig |
| Lundbeck LLC | $346.92 | 2019-2024 | Vyepti |
| Mdd US Operations, LLC | $304.14 | 2019-2025 | Gocovri |
| Pfizer INC. | $301.14 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $235.64 | 2019-2023 | |
| Lilly USA, LLC | $235.20 | 2019-2024 | Emgality, Amyvid |
| Biohaven Pharmaceuticals, INC. | $215.03 | 2021 | |
| Supernus Pharmaceuticals, INC. | $204.15 | 2019-2025 | Qelbree |
| Banner Life Sciences, LLC | $199.31 | 2021-2024 | |
| Biogen, INC. | $197.46 | 2019-2024 | Vumerity, Tysabri, Plegridy |
| Novartis Pharmaceuticals Corporation | $174.50 | 2019-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosalyn Aranas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.